Profiel
Nelson Chau worked as a Vice President at LogicBio Therapeutics, Inc. from 2017 to 2021.
Prior to that, he worked as a Vice President at Translate Bio, Inc. and as a Director of Research at Regulus Therapeutics, Inc. Mr. Chau holds a doctorate degree from The Johns Hopkins University School of Medicine.
Eerdere bekende functies van Nelson Chau
| Bedrijven | Functie | Einde |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2021 |
| REGULUS THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | - |
| TRANSLATE BIO, INC. | Corporate Officer/Principal | - |
Opleiding van Nelson Chau
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |